Witnessing the stock’s movement on the chart, on Wednesday, VolitionRX Ltd (AMEX: VNRX) had a quiet start as it plunged -7.38% to $0.28, before settling in for the price of $0.3 at the close. Taking a more long-term approach, VNRX posted a 52-week range of $0.27-$0.94.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 5.38%. Meanwhile, its Annual Earning per share during the time was 5.38%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 31.34%. This publicly-traded company’s shares outstanding now amounts to $109.62 million, simultaneously with a float of $96.62 million. The organization now has a market capitalization sitting at $34.38 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4141, while the 200-day Moving Average is $0.5563.
VolitionRX Ltd (VNRX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. VolitionRX Ltd’s current insider ownership accounts for 21.32%, in contrast to 21.27% institutional ownership. According to the most recent insider trade that took place on Nov 17 ’25, this organization’s President and CEO bought 20,000 shares at the rate of 0.35, making the entire transaction reach 7,000 in total value, affecting insider ownership by 2,554,847. Preceding that transaction, on Oct 14 ’25, Company’s President and CEO bought 110,000 for 0.51, making the whole transaction’s value amount to 56,100. This particular insider is now the holder of 2,534,847 in total.
VolitionRX Ltd (VNRX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year. VolitionRX Ltd’s EPS increase for this current 12-month fiscal period is 31.34% and is forecasted to reach -0.12 in the upcoming year.
VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators
Let’s observe the current performance indicators for VolitionRX Ltd (VNRX). It’s Quick Ratio in the last reported quarter now stands at 0.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 23.39.
In the same vein, VNRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.23, a figure that is expected to reach -0.05 in the next quarter, and analysts are predicting that it will be -0.12 at the market close of one year from today.
Technical Analysis of VolitionRX Ltd (VNRX)
Going through the that latest performance of [VolitionRX Ltd, VNRX]. Its last 5-days volume of 1.47 million indicated improvement to the volume of 0.5 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 29.89% While, its Average True Range was 34.18.
Raw Stochastic average of VolitionRX Ltd (VNRX) in the period of the previous 100 days is set at 1.53%, which indicates a major fall in contrast to 9.83% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0288 that was lower than 0.0414 volatility it exhibited in the past 100-days period.
